Bottom line
Is NVOH a good fund? The bottom line
NVOH is a managed international stock ETF from DWS (Xtrackers).
Annual fees run 0.19% — about $19 a year on every $10,000 invested, cheaper than 94% of international stock funds we track.
With $4.2 million in net assets and 3 holdings, its largest position is Novo Nordisk A/s (96.9%) and the top 10 make up 99.6% of the portfolio.
What stands out
- Low cost: cheaper than 94% of international stock peers
What to watch
- Concentrated: top 10 holdings are 99.6% of assets
- Small fund ($4.2 million) — small funds are likelier to close
Updated Nov 19, 2026
What NVOH invests in
The Novo Nordisk A/S (B Shares) ADRhedged (the Series) seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market.
The Series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (ADRs) of the Novo Nordisk A/S (B Shares) (the Company). The Series will not invest directly in the Company. ADRs are receipts, issued by an American bank or trust issuer, which evidence ownership of underlying securities issued by a non-U.S. issuer. Generally, ADRs, issued in registered form, are designed for use in the U.S. securities markets. The Series invests in the ADRs of the Company (the Portfolio Securities) and a currency swap (the Currency Hedge Contract) designed to hedge against fluctuations in the exchange rate between the U.S. dollar and the Danish krone (Local Currency). The Currency Hedge Contract is with a counterparty acting as principal. The notional value of the Currency Hedge Contract is adjusted daily based on the current value of the Portfolio…
From the fund's prospectus (filed Apr 29, 2026).
What NVOH costs
On a $10,000 investment, NVOH's 0.19% expense ratio costs about $19 a year. The prospectus estimates $243 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
NVOH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Novo Nordisk A/s NVO | 96.87% |
| 2 | Dreyfus Trsry Securities | 2.79% |
| 3 | Canadian Imperial Bank Of Commerce | -0.08% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 99.6% of the fund. See all top 25 holdings and asset mix →